Viatris

Viatris Inc. is a global healthcare company based in Canonsburg, Pennsylvania, formed in November 2020 from the merger of Mylan N.V. and Pfizer's Upjohn business. The company aims to empower people worldwide to live healthier lives by expanding access to high-quality medicines. With operations in over 165 countries and a workforce of approximately 32,000 to 45,000 employees, Viatris leverages the expertise of its legacy companies in scientific, manufacturing, regulatory, and commercial fields. Viatris offers a diverse portfolio of over 1,400 approved molecules, including globally recognized brands, generics, complex generics, biosimilars, and over-the-counter products. The company addresses significant health challenges, targeting nine of the top ten causes of death identified by the WHO. Viatris is committed to research and development, sustainability, and community engagement, ensuring quality and reliability in its supply chain.